Online Exclusive

CEE and the WHI Estrogen-Alone Trial

The North American Menopause Society responded to a paper, “Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial," which was published April 6, 2011, in the Journal of the American Medical Association. A randomized clinical trial found that conjugated equine estrogen (CEE) use was associated with a decreased risk of invasive breast cancer and much more favorable results for coronary heart disease (CHD), all-cause mortality, and several other outcomes in younger than in older women.


Click here to hear a concise audiocast on NAMS' response by Margery L.S. Gass, MD, NCMP, Executive Director. Dr Margery Gass discusses the conclusions that can be drawn from the recent report on conjugated equine estrogens from the Women’s Health Initiative Estrogen-Alone Trial.


To read NAMS' official statement, click here.


Breaking News

More Headlines